LGVN
USDLongeveron Inc. Class A Common Stock
$0.800-0.020 (-2.439%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$0.820
고가
$0.820
저가
$0.800
거래량
0.38M
기업 기본 정보
시가총액
16.8M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.95M
거래소
NCM
통화
USD
52주 범위
저가 $0.633현재가 $0.800고가 $2.31
관련 뉴스
GlobeNewswire
Longeveron® to Report Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapies for life-threatening, rare pediatric and chronic aging-related conditions,
더 보기
GlobeNewswire
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR's BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHSFull enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II)
더 보기
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기